Ismail-Khan R - Search Results

1

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.

Simon GR, Extermann M, Chiappori A, Williams CC, Begum M, Kapoor R, Haura EB, Ismail-Khan R, Schell MJ, Antonia SJ, Bepler G. Simon GR, et al. Cancer. 2008 May 1;112(9):2021-9. doi: 10.1002/cncr.23360. Cancer. 2008. PMID: 18300255 Free article. Clinical Trial.

2

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database.

Khan MA, Andrews S, Ismail-Khan R, Munster PN, Brem S, King J, Reintgen DS, Sondak VK, Daud AI. Khan MA, et al. Cancer Control. 2006 Jul;13(3):211-7. doi: 10.1177/107327480601300308. Cancer Control. 2006. PMID: 16885917 Free article.

3

Malignant pleural mesothelioma: a comprehensive review.

Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR. Ismail-Khan R, et al. Cancer Control. 2006 Oct;13(4):255-63. doi: 10.1177/107327480601300402. Cancer Control. 2006. PMID: 17075562 Free article. Review.

4

Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality.

Simon GR, Ismail-Khan R, Bepler G. Simon GR, et al. Int J Biochem Cell Biol. 2007;39(7-8):1318-28. doi: 10.1016/j.biocel.2007.05.006. Epub 2007 Jun 12. Int J Biochem Cell Biol. 2007. PMID: 17600754 Free PMC article. Review.

5

A review of triple-negative breast cancer.

Ismail-Khan R, Bui MM. Ismail-Khan R, et al. Cancer Control. 2010 Jul;17(3):173-6. doi: 10.1177/107327481001700305. Cancer Control. 2010. PMID: 20664514 Free article. Review.

6

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.

Munster PN, Thurn KT, Thomas S, Raha P, Lacevic M, Miller A, Melisko M, Ismail-Khan R, Rugo H, Moasser M, Minton SE. Munster PN, et al. Br J Cancer. 2011 Jun 7;104(12):1828-35. doi: 10.1038/bjc.2011.156. Epub 2011 May 10. Br J Cancer. 2011. PMID: 21559012 Free PMC article. Clinical Trial.

7

Urinary symptoms in breast cancer: a systematic review.

Donovan KA, Boyington AR, Ismail-Khan R, Wyman JF. Donovan KA, et al. Cancer. 2012 Feb 1;118(3):582-93. doi: 10.1002/cncr.26324. Epub 2011 Jul 12. Cancer. 2012. PMID: 21751193 Free PMC article. Review.

8

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.

Soliman HH, Jackson E, Neuger T, Dees EC, Harvey RD, Han H, Ismail-Khan R, Minton S, Vahanian NN, Link C, Sullivan DM, Antonia S. Soliman HH, et al. Oncotarget. 2014 Sep 30;5(18):8136-46. doi: 10.18632/oncotarget.2357. Oncotarget. 2014. PMID: 25327557 Free PMC article. Clinical Trial.

9

A phase I study of indoximod in patients with advanced malignancies.

Soliman HH, Minton SE, Han HS, Ismail-Khan R, Neuger A, Khambati F, Noyes D, Lush R, Chiappori AA, Roberts JD, Link C, Vahanian NN, Mautino M, Streicher H, Sullivan DM, Antonia SJ. Soliman HH, et al. Oncotarget. 2016 Apr 19;7(16):22928-38. doi: 10.18632/oncotarget.8216. Oncotarget. 2016. PMID: 27008709 Free PMC article. Clinical Trial.

10

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer.

Soliman H, Khambati F, Han HS, Ismail-Khan R, Bui MM, Sullivan DM, Antonia S. Soliman H, et al. Oncotarget. 2018 Jan 10;9(11):10110-10117. doi: 10.18632/oncotarget.24118. eCollection 2018 Feb 9. Oncotarget. 2018. PMID: 29515795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page